<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Trisna Awaliah Mardis</style></author><author><style face="normal" font="default" size="100%">Aminuddin Syam</style></author><author><style face="normal" font="default" size="100%">Ulfa Najamuddin</style></author><author><style face="normal" font="default" size="100%">Healthy Hidayanti</style></author><author><style face="normal" font="default" size="100%">Citrakesumasari C</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effect of Pumpkin Seed Capsule Supplementation (Cucurbita moschata) and a Spiritual-Based Intervention (Tahajjud Prayer) on Fasting Blood Glucose and Cortisol Levels in Prediabetic Patients: A Quasi-Experimental Study</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Blood glucose</style></keyword><keyword><style  face="normal" font="default" size="100%">Cucurbita moschata</style></keyword><keyword><style  face="normal" font="default" size="100%">Prediabetic State</style></keyword><keyword><style  face="normal" font="default" size="100%">Spiritual Intervention</style></keyword><keyword><style  face="normal" font="default" size="100%">Stress Hormone</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2026</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2026</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">18</style></volume><pages><style face="normal" font="default" size="100%">367-370</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;This study aimed to evaluate the effect of pumpkin seed (&lt;em&gt;Cucurbita moschata&lt;/em&gt;) capsule supplementation combined with a spiritual-based stress reduction intervention on fasting blood glucose (FBG) and cortisol levels among prediabetic patients. &lt;strong&gt;Methods:&lt;/strong&gt; A quasi-experimental study with a nonrandomized pretest-posttest control group design was conducted among 37 prediabetic participants in a primary healthcare setting. The intervention group (n=18) received pumpkin seed capsules (&lt;em&gt;Cucurbita moschata&lt;/em&gt;) (700 mg, twice daily) and participated in a structured spiritual-based night-time practice (Tahajjud prayer) at least three times per week for 30 days. The control group (n=19) received placebo capsules and health education. FBG was measured using a glucometer, and salivary cortisol levels were assessed using immunoassay. Statistical analyses included Wilcoxon signed-rank and Mann–Whitney tests. &lt;strong&gt;Results:&lt;/strong&gt; The intervention group showed a significant reduction in FBG (from 120.06±7.94 mg/dL to 87.72±6.76 mg/ dL; p&amp;lt;0.001), compared to the control group (p&amp;lt;0.001), with a significantly greater reduction between groups (p&amp;lt;0.001). Cortisol levels significantly decreased within both groups; however, the betweengroup difference was not statistically significant (p=0.229). &lt;strong&gt;Conclusions: &lt;/strong&gt;The combination of pumpkin seed supplementation (&lt;em&gt;Cucurbita moschata&lt;/em&gt;) and a spiritual-based intervention significantly improved fasting blood glucose levels in prediabetic patients. Although cortisol levels decreased, the reduction was not significantly different compared to the control group. Due to the simultaneous administration of both interventions, the independent effect of each component cannot be determined. This combined intervention may serve as a complementary strategy for prediabetes management.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">367</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Trisna Awaliah Mardis&lt;sup&gt;1*&lt;/sup&gt;, Aminuddin Syam&lt;sup&gt;1&lt;/sup&gt;, Ulfa Najamuddin&lt;sup&gt;1&lt;/sup&gt;, Healthy Hidayanti&lt;sup&gt;1&lt;/sup&gt;, Citrakesumasari&lt;sup&gt;1&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Magister Of Nutrition, Faculty Of Public Health, Hasanuddin University, Jl. Perintis Kemerdekaan KM 10 Tamalanrea, Makassar 90245, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Titut Harnanik</style></author><author><style face="normal" font="default" size="100%">Ketut Edy Sudiarta</style></author><author><style face="normal" font="default" size="100%">Rudi Pandapotan Napitupulu</style></author><author><style face="normal" font="default" size="100%">Arif Rahman Nurdianto</style></author><author><style face="normal" font="default" size="100%">Ni Ketut Alit Darmayanti</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Hyperbaric Oxygen in Animal Model of Diabetes Nephropathy: Analysis of Blood Glucose, Proteinuria and Kidney Tissue Necrosis Cells</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Blood glucose</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes Nephropaty</style></keyword><keyword><style  face="normal" font="default" size="100%">Hyperbaric Oxygen</style></keyword><keyword><style  face="normal" font="default" size="100%">Kidney Tissue Necrosis Cells</style></keyword><keyword><style  face="normal" font="default" size="100%">Proteinuria</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">1043-1046</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Diabetic nephropathy (DN) is a microvascular complication of diabetes mellitus (DM) and is the main cause of 20 to 40 times higher mortality compared to diabetes without nephropathy. Therefore, the author wants to prove the effect of hyperbaric oxygen therapy (HBO) on changes in blood glucose levels, proteinuria and kidney tissue necrosis cells in DN animal models. This study used 27 male white rats Rattus Norvegicus strain Wistar, weighing 170 - 220 grams, aged 8-12 weeks, healthy and active, divided into 3 groups, namely the normal rats group (G0), the DN rats without HBO group (G1) and the DN rats with HBO group (G2). Making a DN model with Streptozotocin (STZ) induction 75 mg / kgBW intraperitoneally in a single dose. HBO was performed in a 2.4 ATA pressurized air chamber by inhaling 98% O2 for 3 x 30 minutes interspersed with inhaling normal air for 2 x 5 minutes for 5 consecutive days. The results showed a significant decrease in blood glucose levels p = 0.000 (p &amp;lt;0.05). In proteinuria levels, there was an insignificant decrease p = 0.077 (p &amp;gt; 0.05) in G2 compared to G1. Repair of kidney tissue damage was also indicated by a decrease in necrotic cells by 45.45% in G2 compared to G1. These results prove that HBO can repair kidney damage in DN model mice, so HBO is expected to be used as an additional therapy in cases of diabetic nephropathy.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1043</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Titut Harnanik&lt;sup&gt;1,2,*&lt;/sup&gt;, Ketut Edy Sudiarta&lt;sup&gt;1&lt;/sup&gt;, Rudi Pandapotan Napitupulu&lt;sup&gt;1&lt;/sup&gt;, Arif Rahman Nurdianto&lt;sup&gt;1&lt;/sup&gt;, Ni Ketut Alit Darmayanti&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Marine Health, Faculty of Medicine, Hang Tuah University, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Naval Health Institute Drs. Med. R. Rijadi S, Phys., Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ram Niwas Jangir</style></author><author><style face="normal" font="default" size="100%">Gyan Chand Jain</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Evaluation of Antidiabetic Activity of Hydroalcoholic Extract of Cassia fistula Linn. pod in Streptozotocin-Induced Diabetic Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antidiabetic</style></keyword><keyword><style  face="normal" font="default" size="100%">Blood glucose</style></keyword><keyword><style  face="normal" font="default" size="100%">Cassia fistula</style></keyword><keyword><style  face="normal" font="default" size="100%">Glycogen</style></keyword><keyword><style  face="normal" font="default" size="100%">Glycosylated Hemoglobin</style></keyword><keyword><style  face="normal" font="default" size="100%">Streptozotocin</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style  face="normal" font="default" size="100%">July 2017</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">/files/pj-9-5/10.5530pj.2017.5.95/index.html</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">9</style></volume><pages><style face="normal" font="default" size="100%">599-606</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Diabetes mellitus (DM) is a global health problem and the incidence of DM is increasing at alarming rate all over the world. Many Indian medicinal plants have been reported to possess potential antidiabetic activity and could play important role in the management diabetes. &lt;strong&gt;Objective:&lt;/strong&gt; The present study aimed to evaluate antidiabetic activities of 70% ethanolic extract of &lt;em&gt;Cassia fistula&lt;/em&gt; pod in streptozotocin-induced diabetic rats. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; Diabetes was induced in male Wistar rats by single intraperitoneal injection of streptozotocin (60 mg/kg b.wt.). The diabetic rats were administered orally with &lt;em&gt;C. fistula&lt;/em&gt; pod extract at three different doses (100, 250 and 500 mg/kg b.wt./day) for 60 days. The results were compared with standard drug glibenclamide (5 mg/kg b.wt./day) treated rats. &lt;strong&gt;Results:&lt;/strong&gt; The streptozotocin treated diabetic control rats showed a significant increase in the blood glucose and glycosylated hemoglobin (HbA1c) levels with a concomitant decrease in the body weight and glycogen content in the liver as compared to normal control rats. Oral administration of &lt;em&gt;C. fistula&lt;/em&gt; pod extract (100, 250 and 500 mg/kg b.wt./day) or glibenclamide for 60 days showed significant reduction in the blood glucose and HbA1c levels and an elevation in the body weight and hepatic glycogen content as compared to diabetic control rats. Furthermore, treatment with extract (500 mg/kg b.wt.) also showed improvement of oral glucose tolerance test (OGTT) in diabetic rats. These results were comparable to glibenclamide. &lt;strong&gt;Conclusion:&lt;/strong&gt; The results of present study showed that&lt;em&gt; C. fistula&lt;/em&gt; pod extract possess significant antihyperglycemic activity and supports the traditional use of &lt;em&gt;C. fistula&lt;/em&gt; pod for the treatment of diabetes mellitus.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">599</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Ram Niwas Jangir, Gyan Chand Jain&lt;sup&gt;* &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;Centre for Advanced Studies, Department of Zoology, University of Rajasthan, Jaipur, Rajasthan, INDIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Napapach Chaimum-aom</style></author><author><style face="normal" font="default" size="100%">Sanong Chomko</style></author><author><style face="normal" font="default" size="100%">Chusri Talubmook</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Toxicology and Oral glucose Tolerance Test (OGTT) of Thai Medicinal Plant Used for Diabetes controls, Phyllanthus acidus L. (EUPHORBIACEAE)</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Blood glucose</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes</style></keyword><keyword><style  face="normal" font="default" size="100%">Medicinal plant</style></keyword><keyword><style  face="normal" font="default" size="100%">Phyllanthus acidus</style></keyword><keyword><style  face="normal" font="default" size="100%">Toxicity</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2016</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">9</style></volume><pages><style face="normal" font="default" size="100%">58-61</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Aim:&lt;/strong&gt; The present study aimed to investigate toxicity and oral glucose tolerance test (OGTT) of &lt;em&gt;Phyllanthus acidus&lt;/em&gt; leaf extract (PAE) on Wistar rat. &lt;strong&gt;Methods: &lt;/strong&gt;PAE was prepared and administered orally to experimental animals used. The extract was tested for toxicity in rats at a dose of 0, 1,000, 1,500 and 2,000 mg/kg body weight p.o once daily for 14 days. The hypoglycemic effects of PAE on normal rats and orally glucose-induced hyperglycemic rats were compared with distilled water and glibenclamide. A single dose (250 mg/kg body weight) of PAE was administered and blood glucose level was obtained by pricking the tail vain using glucometer at time -30, 0, 30, 60, 120 and 240 minutes. &lt;strong&gt;Results:&lt;/strong&gt; All doses of the extract did not exert any sign or symptom of toxicity and the dead rat was not found. The body weight, white blood cell (WBC), mean corpuscular volume (MCV), platelet (PLT), plateletcrit (PCT), mean platelet volume (MPV), platelet distribution width (PDW), blood chemistry, blood urea nitrogen (BUN), creatinine, alkaling phosphatase (ALP) and organ weight of liver were not significantly different between control and treated rats. However, red blood cell (RBC), hematocrit (HCT), lymphocyte (LYM), and hemoglobin (Hb) at a dose 1,500 mg./kg body weight were significantly lower than those in the control group. The blood glucose levels of PAE treated groups were not different with control and Glybenclamide treated. &lt;strong&gt;Conclusion:&lt;/strong&gt; The findings of the present study can be concluded that the PAE are practically non-toxic at a lower dose.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">58</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Napapach Chaimum-aom&lt;sup&gt;1*&lt;/sup&gt;, Sanong Chomko&lt;sup&gt;2&lt;/sup&gt;, Chusri Talubmook&lt;sup&gt;2&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Ph.D. Candidate, Faculty of Sciences, Kantarawichai, MahaSarakham 44150, Thailand.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Faculty of Science, Kantarawichai, MahaSarakham 44150, Thailand.&lt;/p&gt;
</style></auth-address></record></records></xml>